Literature DB >> 233132

Correlation between benzodiazepine receptor occupation and anticonvulsant effects of diazepam.

S M Paul, P J Syapin, B A Paugh, V Moncada, P Skolnick.   

Abstract

The benzodiazepines are potent anticonvulsants for a wide variety of experimental and clinical seizure disorders. The demonstration of saturable, high-affinity and stereospecific binding sites for the benzodiazepines in the mammalian central nervous system suggests the presence of pharmacological receptors mediating the anticonvulsant properties of these compounds. The good correlation between the anticonvulsant potencies of a series of benzodiazepines and their ability to inhibit 3H-diazepam binding in vitro further supports this hypothesis, but evidence for a direct interaction between benzodiazepines and their receptors, and a subsequent inhibition of seizure activity (or elevation of seizure threshold) is lacking. Recent reports from our laboratory and others have demonstrated the feasibility of labelling benzodiazepine receptors in vivo following parental administration of tritiated benzodiazepine. This technique permits one to study the relationship between the anticonvulsant activity of the benzodiazepines in vivo and the number of 'drug-occupied' receptors in vitro. We now report that there is an excellent correlation between benzodiazepine receptor occupancy by diazepam and protection against pentylenetetrazol-induced seizures. Furthermore, these results demonstrate that only a small fraction of benzodiazepine receptors need be occupied to produce a complete anticonvulsant effect.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 233132     DOI: 10.1038/281688a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  16 in total

1.  Evidence of strain differences in GABA-benzodiazepine coupling.

Authors:  L Wilks; S E File; I L Martin
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

Review 2.  The use of kinetic-dynamic interactions in the evaluation of drugs.

Authors:  D B Campbell
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

3.  Increased Kv1 channel expression may contribute to decreased sIPSC frequency following chronic inhibition of NR2B-containing NMDAR.

Authors:  Shuijin He; Li-Rong Shao; W Bradley Rittase; Suzanne B Bausch
Journal:  Neuropsychopharmacology       Date:  2012-01-04       Impact factor: 7.853

4.  The pharmacokinetics of diazepam and desmethyldiazepam in rat brain and plasma.

Authors:  H Friedman; D R Abernethy; D J Greenblatt; R I Shader
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

Review 5.  Recent studies on the brain benzodiazepine receptor.

Authors:  J L Waddington
Journal:  Ir J Med Sci       Date:  1984-08       Impact factor: 1.568

6.  Dyphenylhydantoin enhancement of diazepam effects on locomotor activity in mice.

Authors:  L Turski; S J Czuczwar; W Turski; M Sieklucka-Dziuba; Z Kleinrok
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

7.  Relationship between receptor occupancy at 37 degrees C and the anticonvulsant effect of flunitrazepam in rats.

Authors:  M Hollander-Jansen; J Dingemanse; M W Langemeijer; M Danhof
Journal:  Pharm Res       Date:  1989-07       Impact factor: 4.200

8.  1-Methyl-beta-carboline (harmane), a potent endogenous inhibitor of benzodiazepine receptor binding.

Authors:  H Rommelspacher; C Nanz; H O Borbe; K J Fehske; W E Müller; U Wollert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-10       Impact factor: 3.000

9.  Long-lasting anticonvulsant effects of diazepam in different mouse strains: correlations with brain concentrations and receptor occupancy.

Authors:  S E File; D J Greenblatt; I L Martin; C Brown
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

Review 10.  The GABA postsynaptic membrane receptor-ionophore complex. Site of action of convulsant and anticonvulsant drugs.

Authors:  R W Olsen
Journal:  Mol Cell Biochem       Date:  1981-09-25       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.